4.4 Article

MSI2-TGF-β/TGF-β R1/SMAD3 positive feedback regulation in glioblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells

Haitao Tang et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)

Review Pharmacology & Pharmacy

Molecular mechanisms for tumour resistance to chemotherapy

Shu-Ting Pan et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)

Review Oncology

Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives

Miriam Lopez-Gomez et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)

Article Multidisciplinary Sciences

Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis

Alexander E. Kudinov et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Biochemistry & Molecular Biology

Temozolomide resistance in glioblastoma multiforme

Sang Y. Lee

GENES & DISEASES (2016)

Review Clinical Neurology

The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence

Brenda Auffinger et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)

Article Clinical Neurology

Dopamine Receptor D2 and Associated microRNAs Are Involved in Stress Susceptibility and Resistance to Escitalopram Treatment

Yi Zhang et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)

Review Clinical Neurology

The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence

Brenda Auffinger et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)

Review Oncology

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention

Samantha Kaufhold et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)

Article Immunology

Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs

Sun-Mi Park et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Article Biotechnology & Applied Microbiology

Optimizing Glioblastoma Temozolomide Chemotherapy Employing Lentiviral-based Anti-MGMT shRNA Technology

Thomas Viel et al.

MOLECULAR THERAPY (2013)

Review Hematology

Musashi 2 in hematopoiesis

Luisa de Andres-Aguayo et al.

CURRENT OPINION IN HEMATOLOGY (2012)

Article Multidisciplinary Sciences

Musashi2 Is Required for the Self-Renewal and Pluripotency of Embryonic Stem Cells

Erin L. Wuebben et al.

PLOS ONE (2012)

Article Oncology

Primary glioblastomas express mesenchymal stem-like properties

Cho-Lea Tso et al.

MOLECULAR CANCER RESEARCH (2006)